| dc.contributor.author | HATEMİ, GÜLEN | |
| dc.contributor.author | Yazici, Yusuf | |
| dc.date.accessioned | 2023-05-29T13:37:11Z | |
| dc.date.available | 2023-05-29T13:37:11Z | |
| dc.identifier.citation | HATEMİ G., Yazici Y., "Outcome measures in Behçet syndrome", Clinical Immunology, cilt.251, 2023 | |
| dc.identifier.issn | 1521-6616 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_377cee4d-dec5-4e22-b21b-54ef6d42218d | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/189070 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85153490137&origin=inward | |
| dc.identifier.uri | https://doi.org/10.1016/j.clim.2023.109341 | |
| dc.description.abstract | Disease assessment has been challenging in Behçet syndrome due to the heterogeneous disease course and multiorgan involvement with variable treatment response. There have been several recent improvements regarding outcome measures including development of a Core Set of Domains for Behçet syndrome and novel instruments for assessing specific organs and overall damage. This review focuses on the current state of outcome measures in Behçet syndrome, unmet needs, and a research agenda towards the development of standardized and validated outcome measure instruments. | |
| dc.language.iso | eng | |
| dc.subject | İmmünoloji ve Alerji | |
| dc.subject | Tıp | |
| dc.subject | Yaşam Bilimleri | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Temel Bilimler | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Yaşam Bilimleri (LIFE) | |
| dc.subject | Klinik Tıp | |
| dc.subject | İmmünoloji | |
| dc.subject | ALERJİ | |
| dc.title | Outcome measures in Behçet syndrome | |
| dc.type | Makale | |
| dc.relation.journal | Clinical Immunology | |
| dc.contributor.department | İstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
| dc.identifier.volume | 251 | |
| dc.contributor.firstauthorID | 4266506 | |
